The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)

被引:2
|
作者
Inchakalody, Varghese P. [1 ,2 ]
Hydrose, Shereena P. [1 ,2 ]
Krishnankutty, Roopesh [3 ]
Merhi, Maysaloun [1 ,2 ]
Therachiyil, Lubna [3 ,12 ]
Nair, Varun Sasidharan [7 ]
Elashi, Asma A. [8 ]
Khan, Abdul Q. [3 ]
Taleb, Sara [6 ]
Raza, Afsheen [1 ,2 ]
Yoosuf, Zeenath Safira K. M. [2 ,8 ]
Fernandes, Queenie [2 ,9 ]
Al-Zaidan, Lobna [1 ,2 ]
Mestiri, Sarra [1 ,2 ]
Taib, Nassiba [1 ,2 ]
Bedhiafi, Takwa [1 ,2 ]
Moustafa, Dina [1 ,2 ]
Assami, Laila [1 ,2 ]
Maalej, Karama Makni [1 ,2 ]
Elkord, Eyad [10 ,11 ]
Uddin, Shahab [4 ,5 ]
Al Homsi, Ussama [1 ,2 ]
Dermime, Said [1 ,2 ]
机构
[1] Hamad Med Corp, Natl Ctr Canc Care & Res, Doha, Qatar
[2] Hamad Med Corp, Interim Translat Res Inst, Translat Canc Res Facil, Doha, Qatar
[3] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar
[4] Acad Hlth Syst, Translat Res Inst, Doha, Qatar
[5] Acad Hlth Syst, Dermatol Inst, Doha, Qatar
[6] Hamad Bin Khalifa Univ, Genom & Precis Med, Doha, Qatar
[7] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany
[8] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar
[9] Qatar Univ, Coll Med, Doha, Qatar
[10] Univ Nizwa, Nat & Med Sci Res Ctr, Translat Canc Res Facil, Nizwa, Oman
[11] Univ Salford, Sch Sci Engn & Environm, Biomed Res Ctr, Manchester, Lancs, England
[12] Qatar Univ, Coll Pharm, Doha, Qatar
关键词
Non small lung cancer; 5; Aza-CdR; Epigenetic regulation; NY-ESO-1; Apoptosis; Intrinsic and extrinsic apoptotic pathway; EXPRESSION; PROTEINS; 5-AZA-2'-DEOXYCYTIDINE; ENRICHMENT; GROWTH;
D O I
10.1016/j.ejphar.2023.175612
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dysregulated epigenetic modifications are common in lung cancer but have been reversed using demethylating agent like 5-Aza-CdR. 5-Aza-CdR induces/upregulates the NY-ESO-1 antigen in lung cancer. Therefore, we investigated the molecular mechanisms accompanied with the epigenetic regulation of NY-ESO-1 in 5-Aza-CdR-treated NCI-H1975 cell line. We showed significant induction of the NY-ESO-1 protein (**p < 0.0097) using Cellular ELISA. Bisulfite-sequencing demonstrated 45.6% demethylation efficiency at the NY-ESO-1 gene pro-moter region and RT-qPCR analysis confirmed the significant induction of NY-ESO-1 at mRNA level (128-fold increase, *p < 0.050). We then investigated the mechanism by which 5-Aza-CdR inhibits cell proliferation in the NCI-H1975 cell line. Upregulation of the death receptors TRAIL (2.04-fold *p < 0.011) and FAS (2.1-fold *p < 0.011) indicate activation of the extrinsic apoptotic pathway. The upregulation of Voltage-dependent anion-selective channel protein 1 (1.9-fold), Major vault protein (1.8-fold), Bax (1.16-fold), and Cytochrome C (1.39-fold) indicate the activation of the intrinsic pathway. We also observed the differential expression of protein Complement C3 (3.3-fold), Destrin (-5.1-fold), Vimentin (-1.7-fold), Peroxiredoxin 4 (-1.6-fold), Fascin (- 1.8-fold), Heme oxygenase-2 (-0.67-fold**p < 0.0055), Hsp27 (-0.57-fold**p < 0.004), and Hsp70 (-0.39-fold **p < 0.001), indicating reduced cell growth, cell migration, and metastasis. The upregulation of 40S ribosomal protein S9 (3-fold), 40S ribosomal protein S15 (4.2-fold), 40S ribosomal protein S18 (2.5-fold), and 60S ribo-somal protein L22 (4.4-fold) implied the induction of translation machinery. These results reiterate the decisive role of 5-Aza-CdR in lung cancer treatment since it induces the epigenetic regulation of NY-ESO-1 antigen, in-hibits cell proliferation, increases apoptosis, and decreases invasiveness.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] 5-AZA treatment induces cytotoxicity and in vitro expression of immunogenic NY-ESO-1 antigen in non-small lung cancer cell NCI-H1975
    Inchakalody, V. P.
    Taleb, S.
    Sherif, S.
    Fernandes, Q.
    Sahir, F.
    Sivaraman, S. K.
    Khan, A. Q.
    Nair, V. Sasidharan
    Ashi, E. A. A.
    Al-Zaidan, L. S.
    Iskandarani, A.
    Krishnankutty, R.
    Therachiyil, L.
    Raza, A.
    Merhi, M.
    Uddin, S.
    Elkord, E.
    Dermime, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Enhancing NY-ESO-1 antigen expression in lung cancer cells through gene hypomethylation using 5-Aza-2′-deoxycytidine
    Dermime, S.
    Inchakalody, V.
    Nair, V.
    El-Ashi, A.
    Taleb, S.
    Fernandes, Q.
    Al-Zaidan, L.
    Iskandarani, A.
    Sivaraman, S.
    Sahir, F.
    Krishnankutty, R.
    Therachiyil, L.
    Merhi, M.
    Raza, A.
    Uddin, S.
    Elkord, E.
    Knuth, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 36 - 36
  • [3] The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer
    Konishi, J
    Toyooka, S
    Aoe, M
    Omura, Y
    Washio, K
    Tsukuda, K
    Shimizu, N
    ONCOLOGY REPORTS, 2004, 11 (05) : 1063 - 1067
  • [4] Expression of Cancer Testis (CT) Antigen NY-ESO-1 in Non-Small-Cell-Lung Cancer and Correlation with Serology
    Jungbluth, A. A.
    Altorki, N.
    Frosina, D.
    Ritter, E.
    Spinelli, C. F.
    Gnjatic, S.
    MODERN PATHOLOGY, 2014, 27 : 463A - 464A
  • [5] Expression of Cancer Testis (CT) Antigen NY-ESO-1 in Non-Small-Cell-Lung Cancer and Correlation with Serology
    Jungbluth, A. A.
    Altorki, N.
    Frosina, D.
    Ritter, E.
    Spinelli, C. F.
    Gnjatic, S.
    LABORATORY INVESTIGATION, 2014, 94 : 463A - 464A
  • [6] The Role of NY-ESO-1 Activated Dendritic Cell Vaccines in Treating Advanced Non-small Cell Lung Cancer
    Dan, Yu
    Tang, Jianli
    Li, Qiasheng
    Zhang, Huanhuan
    Zhou, Chengzhi
    Zheng, Runhui
    Xu, Jun
    CHEST, 2016, 149 (04) : 313A - 313A
  • [7] Significance of immunohistochemical expression of cancer/testis antigen (MAGE-1, MAGE-3, NY-ESO-1) in patients with non-small cell lung cancer
    Sarcevic, B.
    Grah, J.
    Juretic, A.
    Samija, M.
    HISTOPATHOLOGY, 2008, 53 : 359 - 359
  • [8] Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma
    Gjerstorff, Morten F.
    Pohl, Mette
    Olsen, Karen E.
    Ditzel, Henrik J.
    BMC CANCER, 2013, 13
  • [9] Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma
    Morten F Gjerstorff
    Mette Pøhl
    Karen E Olsen
    Henrik J Ditzel
    BMC Cancer, 13
  • [10] DECITABINE GENE MODULATION SENSITIZES HUMAN NON-SMALL CELL LUNG CANCER (NSCLC) TO NY-ESO-1 TCR IMMUNOTHERAPY LETETRESGENE AUTOLEUCEL; GSK3377794) IN VIVO
    Pankov, Dmitry
    Eleftheriadou, Ioanna
    Domogala, Anna
    Brett, Sara
    Patasic, Lea
    Kijewska, Magdalena
    Thripp, Gary
    Euesden, Jack
    Klapwijk, Jan
    Soor, Katrina
    Damm, Miriam
    Hill, Mark D.
    Georgouli, Mirella
    Shalabi, Aiman
    Britten, Cedrik
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A60 - A61